##gff-version 3
##sequence-region P32004 1 1257
P32004	UniProtKB	Signal peptide	1	19	.	.	.	Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3136168;Dbxref=PMID:3136168	
P32004	UniProtKB	Chain	20	1257	.	.	.	ID=PRO_0000015022;Note=Neural cell adhesion molecule L1	
P32004	UniProtKB	Topological domain	20	1120	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Transmembrane	1121	1143	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Topological domain	1144	1257	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Domain	35	125	.	.	.	Note=Ig-like C2-type 1	
P32004	UniProtKB	Domain	139	226	.	.	.	Note=Ig-like C2-type 2	
P32004	UniProtKB	Domain	240	328	.	.	.	Note=Ig-like C2-type 3	
P32004	UniProtKB	Domain	333	420	.	.	.	Note=Ig-like C2-type 4	
P32004	UniProtKB	Domain	425	507	.	.	.	Note=Ig-like C2-type 5	
P32004	UniProtKB	Domain	518	607	.	.	.	Note=Ig-like C2-type 6	
P32004	UniProtKB	Domain	615	712	.	.	.	Note=Fibronectin type-III 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316	
P32004	UniProtKB	Domain	717	810	.	.	.	Note=Fibronectin type-III 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316	
P32004	UniProtKB	Domain	814	916	.	.	.	Note=Fibronectin type-III 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316	
P32004	UniProtKB	Domain	920	1015	.	.	.	Note=Fibronectin type-III 4;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316	
P32004	UniProtKB	Domain	1016	1115	.	.	.	Note=Fibronectin type-III 5;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316	
P32004	UniProtKB	Motif	554	556	.	.	.	Note=Cell attachment site;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Modified residue	1163	1163	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:17081983;Dbxref=PMID:17081983	
P32004	UniProtKB	Modified residue	1178	1178	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P11627	
P32004	UniProtKB	Modified residue	1181	1181	.	.	.	Note=Phosphoserine%3B by CaMK2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8592152;Dbxref=PMID:8592152	
P32004	UniProtKB	Modified residue	1194	1194	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
P32004	UniProtKB	Modified residue	1243	1243	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P32004	UniProtKB	Modified residue	1244	1244	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P11627	
P32004	UniProtKB	Modified residue	1248	1248	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
P32004	UniProtKB	Glycosylation	100	100	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	203	203	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	247	247	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	294	294	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	433	433	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	479	479	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	490	490	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	505	505	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	588	588	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	671	671	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16335952,ECO:0000269|PubMed:19159218;Dbxref=PMID:16335952,PMID:19159218	
P32004	UniProtKB	Glycosylation	726	726	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	777	777	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	825	825	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	849	849	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	876	876	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	979	979	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	1022	1022	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	1030	1030	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	1071	1071	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Glycosylation	1105	1105	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32004	UniProtKB	Disulfide bond	57	114	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00114	
P32004	UniProtKB	Disulfide bond	158	209	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00114	
P32004	UniProtKB	Disulfide bond	264	312	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00114	
P32004	UniProtKB	Disulfide bond	354	404	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00114	
P32004	UniProtKB	Disulfide bond	448	497	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00114	
P32004	UniProtKB	Disulfide bond	539	591	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00114	
P32004	UniProtKB	Alternative sequence	26	31	.	.	.	ID=VSP_046317;Note=In isoform 3. YEGHHV->L;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.6	
P32004	UniProtKB	Alternative sequence	1177	1180	.	.	.	ID=VSP_002591;Note=In isoform 2 and isoform 3. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:1627459,ECO:0000303|Ref.6;Dbxref=PMID:1627459	
P32004	UniProtKB	Natural variant	9	9	.	.	.	ID=VAR_003921;Note=In HSAS. W->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7762552;Dbxref=PMID:7762552	
P32004	UniProtKB	Natural variant	26	1257	.	.	.	ID=VAR_078350;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	30	30	.	.	.	ID=VAR_030403;Note=H->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10797421;Dbxref=PMID:10797421	
P32004	UniProtKB	Natural variant	37	37	.	.	.	ID=VAR_078351;Note=Probable disease-associated mutation found in L1 syndrome%3B loss of localization at the cell surface%3B retention in the endoplasmic reticulum%3B loss of homophilic interactions at the cell surface. I->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19846429,ECO:0000269|PubMed:26891472;Dbxref=PMID:19846429,PMID:26891472	
P32004	UniProtKB	Natural variant	38	38	.	.	.	ID=VAR_078352;Note=No effect on localization at the cell surface. T->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19846429,ECO:0000269|PubMed:26891472;Dbxref=dbSNP:rs201151358,PMID:19846429,PMID:26891472	
P32004	UniProtKB	Natural variant	66	1257	.	.	.	ID=VAR_078353;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	109	1257	.	.	.	ID=VAR_078354;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_078355;Note=No effect on axon guidance activity%2C nor on synapse formation%2C when assayed in a heterologous system. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24155914;Dbxref=dbSNP:rs796052697,PMID:24155914	
P32004	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_003922;Note=In HSAS. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7762552;Dbxref=PMID:7762552	
P32004	UniProtKB	Natural variant	133	1257	.	.	.	ID=VAR_078356;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	138	1257	.	.	.	ID=VAR_078357;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	172	172	.	.	.	ID=VAR_078358;Note=Probable disease-associated mutation found in a patient with L1 syndrome%3B loss of homophilic interactions at the cell surface%3B no effect on the localization at the cell surface. M->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19846429,ECO:0000269|PubMed:26891472;Dbxref=PMID:19846429,PMID:26891472	
P32004	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_003923;Note=In HSAS and MASA. I->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19846429,ECO:0000269|PubMed:7562969;Dbxref=dbSNP:rs137852523,PMID:19846429,PMID:7562969	
P32004	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_078359;Note=Probable disease-associated mutation found in L1 syndrome. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_003924;Note=In HSAS%3B severe%3B reduced axon arborization%3B partial loss of localization at the cell surface%3B retention in the endoplasmic reticulum%3B in neurons%2C restricted to cell bodies and proximal segments of processes%3B loss of axon guidance and of proper synapse formation%2C when assayed in a heterologous system. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19846429,ECO:0000269|PubMed:20621658,ECO:0000269|PubMed:24155914,ECO:0000269|PubMed:7920659,ECO:0000269|PubMed:8556302,ECO:0000269|PubMed:9195224;Dbxref=dbSNP:rs137852521,PMID:19846429,PMID:20621658,PMID:24155914,PMID:7920659,PMID:8556302,PMID:9195224	
P32004	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_030404;Note=In HSAS. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10797421;Dbxref=PMID:10797421	
P32004	UniProtKB	Natural variant	187	198	.	.	.	ID=VAR_078360;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_003925;Note=In HSAS. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8929944;Dbxref=PMID:8929944	
P32004	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_030405;Note=In MASA%3B loss of homophilic interactions at the cell surface%3B no effect on localization at the cell surface. D->Y;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10805190,ECO:0000269|PubMed:19846429,ECO:0000269|PubMed:26891472;Dbxref=PMID:10805190,PMID:19846429,PMID:26891472	
P32004	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_003926;Note=In MASA%3B decrease in cell-matrix adhesion%3B decreased cell migration%3B loss of axon guidance and of proper synapse formation%2C when assayed in a heterologous system%3B no effect on the localization at the cell surface%3B no effect on cell proliferation%2C when transfected in pheochromocytoma PC12 cells%3B no effect on neurite outgrowth%2C when assayed in NGF-treated pheochromocytoma PC12 cells. H->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22973895,ECO:0000269|PubMed:24155914,ECO:0000269|PubMed:7920659,ECO:0000269|PubMed:7920660,ECO:0000269|PubMed:8556302;Dbxref=dbSNP:rs28933683,PMID:22973895,PMID:24155914,PMID:7920659,PMID:7920660,PMID:8556302	
P32004	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_003927;Note=In HSAS%3B decrease in cell-matrix adhesion%3B decreased cell migration%3B no effect on the localization at the cell surface%3B no effect on cell proliferation%2C when transfected in pheochromocytoma PC12 cells%3B no effect on neurite outgrowth%2C when assayed in NGF-treated pheochromocytoma PC12 cells. I->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22973895,ECO:0000269|PubMed:9744477;Dbxref=PMID:22973895,PMID:9744477	
P32004	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_003928;Note=In HSAS and ACCPX. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16650080,ECO:0000269|PubMed:8929944;Dbxref=dbSNP:rs137852526,PMID:16650080,PMID:8929944	
P32004	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_078361;Note=Probable disease-associated mutation found in L1 syndrome. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_003929;Note=In HSAS%3B severe%3B loss of localization to the cell surface%3B retention in the endoplasmic reticulum%3B loss of axon guidance%2C when assayed in a heterologous system. C->Y;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12514225,ECO:0000269|PubMed:22973895,ECO:0000269|PubMed:24155914,ECO:0000269|PubMed:8401576,ECO:0000269|PubMed:8556302;Dbxref=dbSNP:rs137852518,PMID:12514225,PMID:22973895,PMID:24155914,PMID:8401576,PMID:8556302	
P32004	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_030406;Note=In MASA. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9300653;Dbxref=PMID:9300653	
P32004	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_078362;Note=Probable disease-associated mutation found in L1 syndrome. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=dbSNP:rs1131691900,PMID:19846429	
P32004	UniProtKB	Natural variant	309	309	.	.	.	ID=VAR_003930;Note=In MASA%3B decrease in neurite outgrowth%2C when assayed in NGF-treated pheochromocytoma PC12 cells%3B decrease in cell-matrix adhesion%3B decreased cell migration%3B no effect on axon guidance%2C on subcellular location to synaptic terminals%2C nor on proper synapse formation%2C when assayed in a heterologous system%3B no effect on the localization at the cell surface%3B no effect on cell proliferation%2C when transfected in pheochromocytoma PC12 cells. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22973895,ECO:0000269|PubMed:24155914,ECO:0000269|PubMed:7762552;Dbxref=dbSNP:rs367665974,PMID:22973895,PMID:24155914,PMID:7762552	
P32004	UniProtKB	Natural variant	313	313	.	.	.	ID=VAR_078363;Note=Probable disease-associated mutation found in L1 syndrome. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_030407;Note=In HSAS. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10797421;Dbxref=PMID:10797421	
P32004	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_003931;Note=In HSAS and MASA%3B also in a patient with hydrocephalus and Hirschsprung disease. W->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19846429,ECO:0000269|PubMed:9744477;Dbxref=PMID:19846429,PMID:9744477	
P32004	UniProtKB	Natural variant	366	1257	.	.	.	ID=VAR_078364;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	369	369	.	.	.	ID=VAR_078365;Note=Probable disease-associated mutation found in L1 syndrome. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	370	370	.	.	.	ID=VAR_003932;Note=In HSAS and MASA. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10797421,ECO:0000269|PubMed:7562969;Dbxref=dbSNP:rs137852524,PMID:10797421,PMID:7562969	
P32004	UniProtKB	Natural variant	386	386	.	.	.	ID=VAR_003933;Note=In HSAS. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9744477;Dbxref=PMID:9744477	
P32004	UniProtKB	Natural variant	408	408	.	.	.	ID=VAR_030408;Note=In HSAS. N->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10797421;Dbxref=PMID:10797421	
P32004	UniProtKB	Natural variant	415	415	.	.	.	ID=VAR_027512;Note=In HSAS. A->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12435569,ECO:0000269|PubMed:19846429;Dbxref=PMID:12435569,PMID:19846429	
P32004	UniProtKB	Natural variant	421	421	.	.	.	ID=VAR_030409;Note=In HSAS. V->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10797421;Dbxref=PMID:10797421	
P32004	UniProtKB	Natural variant	423	1257	.	.	.	ID=VAR_078366;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	426	426	.	.	.	ID=VAR_030410;Note=In MASA. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9300653;Dbxref=PMID:9300653	
P32004	UniProtKB	Natural variant	439	443	.	.	.	ID=VAR_003934;Note=In HSAS. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9195224;Dbxref=PMID:9195224	
P32004	UniProtKB	Natural variant	452	452	.	.	.	ID=VAR_003935;Note=In HSAS%3B severe. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7920659,ECO:0000269|PubMed:8556302;Dbxref=dbSNP:rs137852520,PMID:7920659,PMID:8556302	
P32004	UniProtKB	Natural variant	473	473	.	.	.	ID=VAR_003936;Note=In HSAS and MASA. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9744477;Dbxref=dbSNP:rs886039408,PMID:9744477	
P32004	UniProtKB	Natural variant	480	480	.	.	.	ID=VAR_078367;Note=Probable disease-associated mutation found in L1 syndrome. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	482	482	.	.	.	ID=VAR_030411;Note=In MASA. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9268105;Dbxref=dbSNP:rs1064794246,PMID:9268105	
P32004	UniProtKB	Natural variant	497	497	.	.	.	ID=VAR_030412;Note=In HSAS. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10797421;Dbxref=PMID:10797421	
P32004	UniProtKB	Natural variant	516	516	.	.	.	ID=VAR_078368;Note=Found in a patient with L1 syndrome%3B unknown pathological significance. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	516	516	.	.	.	ID=VAR_078369;Note=Found in a patient with L1 syndrome%3B unknown pathological significance. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	525	525	.	.	.	ID=VAR_078370;Note=Found in a patient with L1 syndrome%3B unknown pathological significance. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=dbSNP:rs782401498,PMID:19846429	
P32004	UniProtKB	Natural variant	526	526	.	.	.	ID=VAR_030413;Note=In HSAS. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9268105;Dbxref=PMID:9268105	
P32004	UniProtKB	Natural variant	542	542	.	.	.	ID=VAR_030414;Note=In HSAS. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9268105;Dbxref=PMID:9268105	
P32004	UniProtKB	Natural variant	598	598	.	.	.	ID=VAR_003937;Note=In MASA. D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7920660,ECO:0000269|PubMed:8556302;Dbxref=dbSNP:rs137852519,PMID:7920660,PMID:8556302	
P32004	UniProtKB	Natural variant	627	627	.	.	.	ID=VAR_078371;Note=T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=dbSNP:rs398123360,PMID:19846429	
P32004	UniProtKB	Natural variant	632	632	.	.	.	ID=VAR_003938;Note=In MASA. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9452110;Dbxref=PMID:9452110	
P32004	UniProtKB	Natural variant	635	635	.	.	.	ID=VAR_078372;Note=Probable disease-associated mutation found in L1 syndrome%3B loss of localization at the cell surface%3B retention in the endoplasmic reticulum%3B loss of transport into axons%3B loss of neurite outgrowth%3B loss of cell-cell adhesion. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22222883;Dbxref=PMID:22222883	
P32004	UniProtKB	Natural variant	645	645	.	.	.	ID=VAR_078373;Note=Probable disease-associated mutation found in L1 syndrome%3B requires 2 nucleotide substitutions. I->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	655	655	.	.	.	ID=VAR_030415;Note=In HSAS. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9118141;Dbxref=dbSNP:rs1375788131,PMID:9118141	
P32004	UniProtKB	Natural variant	662	1257	.	.	.	ID=VAR_078374;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	674	674	.	.	.	ID=VAR_027513;Note=In MASA%3B associated with callosal agenesis. S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9832035;Dbxref=PMID:9832035	
P32004	UniProtKB	Natural variant	691	691	.	.	.	ID=VAR_003939;Note=In MASA%3B associated with callosal agenesis. A->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9521424,ECO:0000269|PubMed:9832035;Dbxref=PMID:9521424,PMID:9832035	
P32004	UniProtKB	Natural variant	691	691	.	.	.	ID=VAR_030416;Note=In HSAS. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10797421;Dbxref=PMID:10797421	
P32004	UniProtKB	Natural variant	698	698	.	.	.	ID=VAR_003940;Note=In HSAS and MASA%3B associated with callosal agenesis%3B also found in a patient affected by hydrocephalus with Hirschsprung disease. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9521424,ECO:0000269|PubMed:9832035;Dbxref=dbSNP:rs886039409,PMID:9521424,PMID:9832035	
P32004	UniProtKB	Natural variant	714	714	.	.	.	ID=VAR_078375;Note=Probable disease-associated mutation found in L1 syndrome. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	739	739	.	.	.	ID=VAR_030417;Note=R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10797421;Dbxref=dbSNP:rs142424573,PMID:10797421	
P32004	UniProtKB	Natural variant	741	741	.	.	.	ID=VAR_030418;Note=In HSAS. M->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9268105;Dbxref=PMID:9268105	
P32004	UniProtKB	Natural variant	751	751	.	.	.	ID=VAR_030419;Note=In HSAS. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10797421;Dbxref=PMID:10797421	
P32004	UniProtKB	Natural variant	752	752	.	.	.	ID=VAR_014421;Note=In HSAS and MASA%3B also found in a patient with the diagnosis of L1 syndrome%3B also in a patient with hydrocephalus and Hirschsprung disease. V->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11857550,ECO:0000269|PubMed:19846429,ECO:0000269|PubMed:9268105;Dbxref=dbSNP:rs137852525,PMID:11857550,PMID:19846429,PMID:9268105	
P32004	UniProtKB	Natural variant	754	754	.	.	.	ID=VAR_078376;Note=Probable disease-associated mutation found in L1 syndrome. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	760	1257	.	.	.	ID=VAR_078377;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	768	768	.	.	.	ID=VAR_003941;Note=In HSAS. V->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7762552;Dbxref=PMID:7762552	
P32004	UniProtKB	Natural variant	768	768	.	.	.	ID=VAR_030420;Note=Decreased cell-cell adhesion%3B no effect on subcellular localization%3B no effect on neurite outgrowth. V->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22222883,ECO:0000269|PubMed:9268105;Dbxref=dbSNP:rs36021462,PMID:22222883,PMID:9268105	
P32004	UniProtKB	Natural variant	770	770	.	.	.	ID=VAR_027514;Note=In MASA%3B associated with callosal agenesis. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16816908;Dbxref=dbSNP:rs148516831,PMID:16816908	
P32004	UniProtKB	Natural variant	784	784	.	.	.	ID=VAR_003942;Note=In HSAS. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9195224;Dbxref=dbSNP:rs797045674,PMID:9195224	
P32004	UniProtKB	Natural variant	789	1257	.	.	.	ID=VAR_078378;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19846429,ECO:0000269|PubMed:26891472;Dbxref=PMID:19846429,PMID:26891472	
P32004	UniProtKB	Natural variant	811	1257	.	.	.	ID=VAR_078379;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	891	1257	.	.	.	ID=VAR_078380;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	901	1257	.	.	.	ID=VAR_078381;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	935	935	.	.	.	ID=VAR_003943;Note=In HSAS. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9521424;Dbxref=PMID:9521424	
P32004	UniProtKB	Natural variant	936	948	.	.	.	ID=VAR_003944;Note=In HSAS. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9195224;Dbxref=PMID:9195224	
P32004	UniProtKB	Natural variant	941	941	.	.	.	ID=VAR_003945;Note=In HSAS and MASA%3B decrease in neurite outgrowth%2C when assayed in NGF-treated pheochromocytoma PC12 cells%3B decrease in cell-matrix adhesion%3B decreased cell migration%3B no effect on the localization at the cell surface%3B no effect on cell proliferation%2C when transfected in pheochromocytoma PC12 cells. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22973895,ECO:0000269|PubMed:7762552;Dbxref=PMID:22973895,PMID:7762552	
P32004	UniProtKB	Natural variant	958	958	.	.	.	ID=VAR_059413;Note=L->V;Dbxref=dbSNP:rs35902890	
P32004	UniProtKB	Natural variant	1036	1036	.	.	.	ID=VAR_078382;Note=In HSAS%3B partial loss of localization at the cell surface%3B retention in the endoplasmic reticulum%3B in neurons%2C partial loss of localization to axons%2C but enriched on proximal dendrites. W->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20621658;Dbxref=PMID:20621658	
P32004	UniProtKB	Natural variant	1064	1257	.	.	.	ID=VAR_078383;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	1070	1070	.	.	.	ID=VAR_003946;Note=In HSAS%3B partial loss of axon guidance and loss of proper synapse formation%2C when assayed in a heterologous system. Y->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24155914,ECO:0000269|PubMed:7762552;Dbxref=PMID:24155914,PMID:7762552	
P32004	UniProtKB	Natural variant	1071	1071	.	.	.	ID=VAR_078384;Note=Probable disease-associated mutation found in L1 syndrome. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	1080	1080	.	.	.	ID=VAR_078385;Note=Probable disease-associated mutation found in L1 syndrome. L->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19846429;Dbxref=PMID:19846429	
P32004	UniProtKB	Natural variant	1194	1194	.	.	.	ID=VAR_003947;Note=In HSAS and MASA. S->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7881431,ECO:0000269|PubMed:8556302;Dbxref=dbSNP:rs137852522,PMID:7881431,PMID:8556302	
P32004	UniProtKB	Natural variant	1224	1224	.	.	.	ID=VAR_003948;Note=In HSAS. S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9744477;Dbxref=PMID:9744477	
P32004	UniProtKB	Natural variant	1239	1239	.	.	.	ID=VAR_030421;Note=G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10797421;Dbxref=PMID:10797421	
P32004	UniProtKB	Mutagenesis	1147	1153	.	.	.	Note=Loss of axon guidance%2C when assayed in a heterologous system%2C but normal synapse formation. KGGKYSV->AGGAASA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24155914;Dbxref=PMID:24155914	
P32004	UniProtKB	Sequence conflict	4	4	.	.	.	Note=A->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P32004	UniProtKB	Sequence conflict	216	216	.	.	.	Note=T->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P32004	UniProtKB	Sequence conflict	250	250	.	.	.	Note=S->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P32004	UniProtKB	Sequence conflict	276	277	.	.	.	Note=WL->SV;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P32004	UniProtKB	Sequence conflict	288	288	.	.	.	Note=V->A;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P32004	UniProtKB	Sequence conflict	357	357	.	.	.	Note=Q->E;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P32004	UniProtKB	Sequence conflict	515	515	.	.	.	Note=K->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P32004	UniProtKB	Sequence conflict	626	626	.	.	.	Note=L->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P32004	UniProtKB	Sequence conflict	660	660	.	.	.	Note=E->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P32004	UniProtKB	Sequence conflict	936	936	.	.	.	Note=L->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P32004	UniProtKB	Sequence conflict	1116	1117	.	.	.	Note=GF->WLC;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P32004	UniProtKB	Sequence conflict	1164	1164	.	.	.	Note=E->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
